A large long-term study on the use of the big-selling weedkiller glyphosate by agricultural workers in the U.S. has found no firm link between exposure to the pesticide and cancer, scientists said on November 9.
Published in the Journal of the National Cancer Institute (JNCI), the study found there was no association between glyphosate, the main ingredient in Monsanto’s popular herbicide RoundUp, “and any solid tumors or lymphoid malignancies overall, including non-Hogkin Lymphoma (NHL) and its subtypes.”
It said there was “some evidence of increased risk of acute myeloid leukemia (AML) among the highest exposed group,” but added this association was “not statistically significant.”
The findings are likely to impact legal proceedings in the U.S. against Monsanto, in which more than 180 plaintiffs are claiming exposure to RoundUp gave them cancer, allegations that Monsanto denies.
The findings may also influence a crucial decision due by the end of the year on whether glyphosate should be re-licensed for sale across the European Union.
EU countries had been due to vote on the issue on November 9, but again failed to agree to a proposal for a five-year extension.| | | Next → | Single Page